AAN 2022 Poster - Pharmacokinetics, Pharmacodynamics, and Safety of the Highly Selective Dopamine D1/D5 Agonist Tavapadon: Summary of Early Phase Clinical Studies

AAN 2022 Poster - Levodopa and Dopamine Agonist Medication Utilization among Patients with Parkinson’s Disease Enrolled in Commercial and Medicare Advantage Part D Health Plans

AAN 2022 Presentation - Darigabat: pronounced antiepileptic activity in the mesial temporal lobe mouse model of drug-resistant focal epilepsy

AAN 2022 Poster - Ensuring the Continuity of Data Collection in a Focal Epilepsy Clinical Trial During the COVID-19 Pandemic

4Q 2021 Financial Results & Business Update

Topline Results for Darigabat in Phase 1 Acute Anxiety Clinical Trial Presentation

J.P. Morgan Healthcare Conference Presentation

Evaluation of M4 Muscarinic Receptor Occupancy by CVL-231 in Nonhuman Primates

CVL-231: Results From an Early Proof-Of-Concept Study in Patients With Schizophrenia

Cerevel Therapeutics Corporate Presentation